Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

ANCN

Anchiano Therapeutics (ANCN)

Anchiano Therapeutics Ltd
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:ANCN
일자시간출처헤드라인심볼기업
2023/06/1705:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
2023/06/0520:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
2023/05/2005:07Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ANCNAnchiano Therapeutics Ltd
2023/05/1119:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ANCNAnchiano Therapeutics Ltd
2023/03/2320:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANCNAnchiano Therapeutics Ltd
2023/03/2320:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANCNAnchiano Therapeutics Ltd
2023/03/2320:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANCNAnchiano Therapeutics Ltd
2023/03/2305:46Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ANCNAnchiano Therapeutics Ltd
2023/02/2121:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
2023/02/2120:20Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ANCNAnchiano Therapeutics Ltd
2023/01/1206:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
2023/01/0606:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANCNAnchiano Therapeutics Ltd
2023/01/0606:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANCNAnchiano Therapeutics Ltd
2023/01/0321:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
2022/11/2920:17Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ANCNAnchiano Therapeutics Ltd
2022/11/1821:54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANCNAnchiano Therapeutics Ltd
2022/11/1806:57Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANCNAnchiano Therapeutics Ltd
2022/11/1621:21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
2022/11/1606:04Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ANCNAnchiano Therapeutics Ltd
2022/11/1506:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
2022/11/1106:13Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ANCNAnchiano Therapeutics Ltd
2022/08/1605:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ANCNAnchiano Therapeutics Ltd
2022/08/1220:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
2022/06/2120:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
2022/06/0819:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
2022/05/3123:31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ANCNAnchiano Therapeutics Ltd
2022/05/2605:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANCNAnchiano Therapeutics Ltd
2022/05/2005:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANCNAnchiano Therapeutics Ltd
2022/05/1219:21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
2022/04/2905:07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ANCNAnchiano Therapeutics Ltd
 검색 관련기사 보기:NASDAQ:ANCN